ULBI vs. GWH, ELVA, NVX, CBAT, STEM, FLUX, DFLI, SES, ITI, and MX
Should you be buying Ultralife stock or one of its competitors? The main competitors of Ultralife include ESS Tech (GWH), Electrovaya (ELVA), NOVONIX (NVX), CBAK Energy Technology (CBAT), Stem (STEM), Flux Power (FLUX), Dragonfly Energy (DFLI), SES AI (SES), Iteris (ITI), and Magnachip Semiconductor (MX).
Ultralife (NASDAQ:ULBI) and ESS Tech (NYSE:GWH) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.
In the previous week, ESS Tech had 12 more articles in the media than Ultralife. MarketBeat recorded 14 mentions for ESS Tech and 2 mentions for Ultralife. Ultralife's average media sentiment score of 0.59 beat ESS Tech's score of 0.05 indicating that Ultralife is being referred to more favorably in the media.
Ultralife has higher revenue and earnings than ESS Tech. ESS Tech is trading at a lower price-to-earnings ratio than Ultralife, indicating that it is currently the more affordable of the two stocks.
Ultralife has a net margin of 6.19% compared to ESS Tech's net margin of -1,028.89%. Ultralife's return on equity of 10.31% beat ESS Tech's return on equity.
Ultralife has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, ESS Tech has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500.
30.7% of Ultralife shares are held by institutional investors. Comparatively, 46.8% of ESS Tech shares are held by institutional investors. 42.7% of Ultralife shares are held by company insiders. Comparatively, 1.8% of ESS Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Ultralife received 249 more outperform votes than ESS Tech when rated by MarketBeat users. Likewise, 71.51% of users gave Ultralife an outperform vote while only 35.29% of users gave ESS Tech an outperform vote.
Ultralife currently has a consensus price target of $13.00, indicating a potential upside of 5.01%. ESS Tech has a consensus price target of $2.11, indicating a potential upside of 167.16%. Given ESS Tech's higher probable upside, analysts clearly believe ESS Tech is more favorable than Ultralife.
Summary
Ultralife beats ESS Tech on 12 of the 18 factors compared between the two stocks.
Get Ultralife News Delivered to You Automatically
Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ultralife Competitors List
Related Companies and Tools
